Despite recent advances in blood glucose control, the continually rising incidence of diabetes leads to an ever- increasing burden of disease complications. Major limitations to treatment include inability to bioengineer beta cell replacement for both type 1 and 2 diabetes, as well as to monitor and image the development of the disease, and to engineer repair of diabetic tissues. Such advances depend on innovations and discoveries throughout the physical and biological sciences, and the ability to bring these advances to the relevant clinical problems. The following examples describe current relevant challenges that are intimately dependent on advances in basic and translational sciences. (1) Progress in cell therapy and tissue engineering promises major breakthroughs in repair of diabetic tissues, but model systems as well as noninvasive imaging of potential replacement cells will be needed to ascertain delivery to target sites. (2) Novel and hybrid imaging systems need to be developed, including microscopic and macroscopic approaches such as PET and optical or photoacoustic imaging are needed to gain deeper and finer assessment of tissue pathologies. (3) Nanoparticles with multimodality imaging capabilities and drug payloads need to be optimized and moved into clinical trials. To transform diabetes outcomes, these and other challenges must be met by interdisciplinary teams of engineers, physicists, computer scientists, biologists, and physicians working together at the interfaces between biology, technology, and medicine. This program seeks to enable these processes, in order to bring advances in technology and engineering to bear on the challenges of research and translation to improved therapeutic outcome, by training a new generation of researchers with strength in physical science and engineering, and with intimate exposure to and involvement in relevant areas of biomedical research. Dually mentored pre-Doctoral and post-Doctoral researchers will develop and apply novel imaging, modeling (both computational and experimental) and engineering approaches to key questions in diabetes and associated pathologies.

Public Health Relevance

Diabetes is increasingly a disease of epidemic proportions with debilitating consequences. To develop truly novel approaches to the disease, a new generation of researchers with the capabilities to develop and implement advances in technology and engineering for this purpose needs to be nurtured and developed. Thus the training of interdisciplinary engineering scientists for medical research is critical, and the goal of this program

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
1T32DK108742-01
Application #
9073777
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK-B)
Program Officer
Castle, Arthur
Project Start
2016-06-01
Project End
2021-05-31
Budget Start
2016-06-01
Budget End
2017-05-31
Support Year
1
Fiscal Year
2016
Total Cost
$159,572
Indirect Cost
$9,450
Name
Washington University
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Guilak, Farshid; Nims, Robert J; Dicks, Amanda et al. (2018) Osteoarthritis as a disease of the cartilage pericellular matrix. Matrix Biol 71-72:40-50
Emfinger, Christopher H; Yan, Zihan; Welscher, Alecia et al. (2018) Contribution of Systemic Inflammation to Permanence of KATP-induced Neonatal Diabetes in Mice. Am J Physiol Endocrinol Metab :
Emfinger, Christopher H; Welscher, Alecia; Yan, Zihan et al. (2017) Expression and function of ATP-dependent potassium channels in zebrafish islet ?-cells. R Soc Open Sci 4:160808